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Abstract
Objective—Estimates of ultrasonic attenuation (the loss of energy as an ultrasonic wave
propagates through tissue) have been used to evaluate the structure and function of tissues in
health and disease. The purpose of this research was to develop a method to estimate ultrasonic
cervical attenuation during human pregnancy using a clinical ultrasound system.
Methods—Forty women underwent a cervical scan once during pregnancy with the Zonare®
z.one clinical ultrasound system using a 4–9-MHz endovaginal transducer. This ultrasound system
provides access to radiofrequency (RF) image data for processing and analysis. In addition, a scan
of a tissue-mimicking phantom with a known attenuation coefficient was acquired and used as a
reference. The same settings and transducer used in the clinical scan were used in the reference
scan. Digital data of the beam-formed image were saved in Digital Imaging and Communications
in Medicine (DICOM) format on a flash drive and converted to RF data on a personal computer
using a Matlab® program supplied by Zonare. Attenuation estimates were obtained using an
algorithm that was independently validated using tissue-mimicking ultrasonic phantoms.
Results—RF data were acquired and analyzed to estimate attenuation of the human pregnant
cervix. Regression analysis revealed that attenuation was: a predictor of the interval from
ultrasound examination to delivery (β = 0.43, P = 0.01); not a predictor of gestational age at time
of examination (β = −0.23, P = 0.15); and not a predictor of cervical length (β = 0.077, P = 0.65).
Conclusions—Ultrasonic attenuation estimates have the potential to be an early and objective
non-invasive method to detect interval between examination and delivery. We hypothesize that a
larger sample size and a longitudinal study design will be needed to detect gestational age-
associated changes in cervical attenuation.
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INTRODUCTION
Preterm birth is a leading cause of infant morbidity and mortality worldwide. Assessment of
uterine contractility and cervical change by digital examination have been considered to be a
method to diagnose preterm labor1. Since the introduction of tocolytics, preterm birth rates
have not been reduced2–5 and the medications carry significant maternal and fetal risks2,6–
9. Evidence suggests that ripening of the cervix precedes uterine contractions and
subsequent delivery of the fetus10,11. Cervical ripening is a process characterized by
collagen disorganization12–14, decreased collagen concentration and increased water
content13–19. A ripened cervix, with loss of the mucus barrier, may be the initial
mechanism leading to a cascade of events (increased inflammation, production of cytokines
and enzymes, and loss of cervical mucus) that result in preterm birth20–22. Thus,
maintaining a closed unripe cervix with an intact cervical mucus barrier during pregnancy is
critical for preventing preterm birth. Cervical changes that occur before preterm birth go
undetected because women do not have symptoms (contractions) or signs (vaginal
discharge)11,23. Measurement of early cervical changes (increased collagen disorganization
and decreased collagen concentration) associated with remodeling of the extracellular matrix
then becomes a medically significant milestone that may predict preterm labor and birth.
There is considerable interest in developing new imaging techniques to accurately predict
cervical changes associated with full-term and preterm labor1,24–26. Cervical shortening
and dilation can be detected using clinical ultrasound systems. However, an objective non-
invasive ultrasonic method to determine tissue property changes (increased collagen
disorganization and water concentration) associated with cervical ripening does not exist.
Estimates of ultrasonic attenuation (the loss of energy as an ultrasonic wave propagates
through tissue)27 have been used to evaluate the structure and function of tissues in health
and disease28–36. Attenuation has been observed to be related to tissue stiffness, collagen
concentration and water concentration28–31,37. During pregnancy, as the collagen-rich
cervix prepares for labor and birth, the cervix transforms from a rigid structure to a soft,
extensible structure. It is thus hypothesized that by estimating changes in ultrasonic
attenuation, these dynamic changes in tissue structure and function can be detected.
Our previous work in an animal model demonstrated that the decreased collagen
concentration associated with cervical ripening clearly affected ultrasonic attenuation in
cervical tissue18. We found that estimates of attenuation corresponded to gestational age
changes in the rat cervix as ripening occurred18. In the rat cervix, attenuation was greater in
the non-pregnant cervix and at an early gestational age, and decreased as pregnancy
advanced towards full-term18. We attributed those changes in attenuation to changes in
collagen disorganization13,18. Figure 1 presents atomic force microscopy images of a non-
pregnant rat cervix, showing tightly packed and organized collagen bundles, and a day-21
pregnant rat cervix (the day on which rats typically deliver), showing highly disorganized
collagen. Similar changes in collagen disorganization occur in human pregnancy as the
cervix ripens38. We postulate that the development of methods to detect cervical attenuation
in human pregnancy might be a useful means of estimating cervical tissue-property changes
associated with cervical ripening.
Recently, a clinical ultrasound system (z.one; Zonare® Medical Systems, Inc., Mountain
View, CA, USA) became available that allows access to radiofrequency (RF) image data of
the human pregnant cervix similar to our previous animal studies18,39. Our previous studies
in the animal model used ultrasound research data-acquisition systems (Panametrics,
Waltham, MA, USA) and single-element high-frequency transducers (35 and 65
MHz)18,39. We wanted to extend our previous work, namely detecting cervical tissue
changes in the animal model, to those changes occurring in human pregnancy by estimating
McFarlin et al. Page 2
Ultrasound Obstet Gynecol. Author manuscript; available in PMC 2011 August 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
ultrasonic attenuation of the human pregnant cervix with a clinical ultrasound system using a
phased-array transducer. The purpose of this study was to develop a method to estimate
ultrasonic attenuation in the human pregnant cervix using a clinical ultrasound system that
provided access to RF image data for processing and analysis.
METHODS
Forty women underwent a cervical ultrasound examination once during pregnancy, using the
z.one clinical ultrasound system. No longitudinal assessments of cervical attenuation were
conducted on the women who participated in the study. The gestational age at the time of the
cervical ultrasound examination ranged from 10 to 41 weeks. The inclusion criteria were:
women with a live intrauterine pregnancy of between 10 and 42 weeks of gestation; and
willingness to participate in the study. Women with a cerclage, who had undergone a loop
electrosurgical excision procedure (LEEP) or a cone biopsy, or who had experienced rupture
of membranes, vaginal bleeding or a fetal death, were excluded from the study.
All ultrasound data were acquired by one investigator (B.L.M.) with the same system presets
for each examination. Two sagittal scans of the cervix, which included visualization of the
internal and external os, were acquired for each woman using a 4–9-MHz (6.8-MHz center
frequency) endovaginal transducer. Attenuation estimates and cervical length measurements
were conducted for each of the two images on each woman’s cervix. Care was taken to
obtain the scan in the same manner each time. Cervical length was measured, from the
internal os to the external os, on the same image on which data would be analyzed for
ultrasound attenuation. In addition, a scan of a tissue-mimicking phantom (University of
Wisconsin, Madison, WI, USA), acquired with the same 4–9-MHz endovaginal transducer,
was used to obtain the reference ultrasound signal for use when estimating cervical
attenuation. The tissue-mimicking phantom was custom-made using 45- to 53-µm glass
beads in agar and has been well characterized40 and used to obtain reference ultrasound data
for research at the Bioacoustics Research Laboratory at the University of Illinois at Urbana-
Champaign (Urbana, IL, USA). The attenuation coefficient of the tissue-mimicking phantom
was 0.64 dB/cm-MHz and varied by as much as 0.15 dB/cm-MHz when evaluated among
eight ultrasound research laboratories40. Figure 2 displays an ultrasound image of a tissue-
mimicking phantom obtained with the 4–9-MHz endovaginal transducer used in this study.
The mean attenuation of the phantom, measured using the endovaginal transducer, was 0.64
dB/cm-MHz (±0.13 dB/cm-MHz). The settings of the ultrasound system were identical
between the human scan and the reference phantom scan. The performance characteristics of
the Zonare Medical Systems 4–9-MHz endovaginal transducer are summarized in Table 1.
Digital Imaging and Communications in Medicine (DICOM) data of the beam-formed
image were saved on a flash drive and converted to RF data on a personal computer using a
Matlab® (Mathworks, Natick, MA, USA) program supplied by Zonare. Gestational age of
the fetus was determined from the first-trimester ultrasound examination. Cervical length
was measured at the time of the examination. Pregnancy characteristics and previous history
of preterm birth were collected via patient interview. None of the women was subjected to a
digital examination of the cervix. Gestational age at delivery and neonatal outcome data
were acquired by telephone verbal report from the patient because most of the women
delivered at various institutions throughout the states of Illinois and Indiana. All of the
women were cognisant of infant birth weight, Apgar scores and date of delivery.
The attenuation estimates were obtained using an algorithm that was previously validated in
tissue-mimicking ultrasound phantoms41. Briefly, backscattered RF waveforms were
obtained from an unknown sample and from a reference phantom with a known attenuation
coefficient, using the same transducer and system settings. Attenuation is defined as the loss
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of signal amplitude with depth as a function of frequency, and attenuation coefficient is the
attenuation normalized to distance and/or frequency. The power spectra of both the
reference phantom and the unknown sample are functions of frequency and propagation
depth in the sample. The frequency dependence of the power spectra depends on the system
transfer function, attenuation, scattering and diffraction of sound waves. The system transfer
function and the diffraction term are approximated to be the same for both the reference
sample and the phantom and can be eliminated by dividing the power spectra from the two
samples and taking the logarithm. Determining the rate of change with depth into the tissue
of this ratio for each frequency eliminates the scattering terms, assuming that the scattering
properties do not vary with depth over the region of interest (ROI). Averaging the remaining
coefficients with respect to frequency, and adding the attenuation coefficient of the reference
phantom, then gives an estimate of the attenuation coefficient (dB/cm-MHz) in the unknown
sample.
One investigator (B.L.M.) chose the ROIs for obtaining attenuation estimates. The ROIs
were chosen based upon adequate size of ROI in homogeneous tissue (no cystic areas or
amniotic fluid). Because of the tissue architecture, the same ROI could not be sampled in
each image. Therefore, we used one attenuation estimate value for each patient. The
investigators processing the RF data (T.A.B. and Y.L.) were blinded to gestational age and
clinical information about the patients. In order to obtain an error of less than 10%, the ROI
must be at least 40 wavelengths (1 cm in length for a 6-MHz transducer) and contain at least
30 beam lines. Institutional Review Board approval of the study was obtained at Rush
University and at the University of Illinois at Chicago.
The purpose of this study was to develop methodology to estimate attenuation using a
clinical ultrasound system. Hence, the study was not powered to detect differences in
attenuation and cervical length as a function of gestational age at the time of examination.
However, descriptive statistics and one-way analysis of variance (ANOVA) (two-tailed
tests) were calculated for gestational age at the time of examination (SPSS 16.0; SPSS,
Chicago, IL, USA). Scatterplots with linear regression lines and 95% CI were calculated to
display the relationship between attenuation and interval to delivery, cervical length and
gestational age at the time of examination. An alpha level of 0.05 was used for all statistical
tests.
RESULTS
Forty women participated in the study. Seven women delivered at <37 weeks of gestation.
Table 2 displays the characteristics of women in the study. Regression analysis revealed that
attenuation was: (1) a predictor of the interval from ultrasound examination to delivery (β =
0.43, P = 0.011); (2) not a predictor of gestational age at time of examination (β = −0.23, P
= 0.15); and (3) not a predictor of cervical length (β = 0.077, P = 0.65). Figure 3 displays
scatterplots of cervical-attenuation estimates as a function of interval from ultrasound
examination to delivery, gestational age at time of examination and cervical length, for the
women in the study. Table 3 displays the characteristics of the women in the study who
delivered preterm. Figure 2 displays the attenuation coefficient of the tissue-mimicking
phantom (mean = 0.64 dB/cm-MHz, SD = 0.13 dB/cm-MHz). Similar attenuation estimate
results were reported by other investigators who used this phantom40.
Table 4 summarizes the characteristics of women who had a cervical length of <2.5 cm at
the time of the ultrasound examination. Patient no. 35 had a very short cervix, a moderate
attenuation value and did not deliver for 11 more weeks. She was monitored and did not
receive tocolytics as she was not contracting. Patient no. 41 was noted to have a cervical
length of 2.26 cm at 18 weeks, a moderately high attenuation value and did not deliver for
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19 more weeks. Figure 4 displays images of the cervices of two women who participated in
the study – one at 14 weeks of gestation and one at 38 weeks of gestation. Ultrasound B-
mode images of the cervices (Figures 4a and c) of the two women were created along with
corresponding superimposed maps of the attenuation estimates for the cervices (Figures 4b
and d). Each pixel in the superimposed image represents a mean attenuation value for the
intended ROI of the cervix. We wanted to evaluate both the internal and external portions of
the cervix, but this was not always possible because of inhomogeneities and architecture
variances of the cervical tissue. In the two cases presented in Figure 4, mean attenuation was
greater in the 14-week cervix than in the 38-week cervix, although there was little change in
cervical length measurements (3.1 cm for the 14-week cervix and 3.5 cm for the 38-week
cervix).
Like the cervical attenuation estimates in our previous animal studies18,39, considerable
between-subject attenuation variability was noted (Figure 3a). Unlike attenuation estimates
in the previous animal cervical studies, however, the attenuation variability across the cervix
for a specific patient was reduced compared with that in rats as a result of the larger ROIs
sampled in the larger human cervix.
DISCUSSION
The results of this study demonstrate that we were able to acquire and analyze useable RF
data to yield estimates of local attenuation in the human pregnant cervix. Local ultrasonic
attenuation has been successfully used to characterize the structure and health of biological
tissues. Applications have included diagnosing diffuse liver disease42–45, monitoring tissue
changes after high-intensity ultrasound therapy46, assessing changes in the liver following
prednisone treatment47, differentiating between benign and malignant tissue in the
prostate48 and assessing the mineral content of bone49–52. Attenuation of tissue has been
observed to decrease significantly as water concentration increases and density
decreases53,54. With the dynamic changes in cervix microstructure (increased collagen
disorganization and decreased collagen concentration) and water concentration during the
ripening process, it is reasonable to consider using attenuation to detect changes in the
cervix that are associated with cervical ripening. Our own research in the rat cervix observed
significant decreases in attenuation as pregnancy progressed towards full-term18, as well as
significant correlations of attenuation with cervix tissue water concentration (ex vivo study: r
= 0.98, P < 0.001)18.
Significant between-subject variability in attenuation was observed. Our previous rat-cervix
attenuation estimates also showed marked between- subject variability, even though the rat
pregnancy gestational age is known to within 12 h of conception, suggesting biologic
variation in cervical tissue starting points. These findings suggest that future longitudinal
repeated-measure designs will be needed to detect cervical change leading to labor, as each
patient may have her own cervix attenuation starting point. It is possible that the patterns of
cervical change will be different in women delivering at full-term or at preterm. It is
promising that in this small sample size, attenuation estimates were associated with interval
to delivery. There may be a critical level of attenuation that corresponds to signaling of
impending labor. Note that the cervical length in the Figure 4 images was not markedly
different, but the attenuation values and gestational age were very different. The lack of
relationship between cervical-attenuation estimates and cervical length suggests that the
process of microstructural tissue property changes and cervical length may be independent
of, or at least not concurrent with, attenuation.
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Limitations
The goal of this research was to construct attenuation maps of the entire cervix, or at least be
consistent in sampling the internal and external portions of the cervix. The attenuation
algorithm assumes homogeneous tissue. We selected cervical ROIs that appeared to be
homogeneous tissue, without any cystic areas. Because of the cervical tissue architecture,
the same ROIs could not be uniformly sampled in each individual case. Therefore, we used
one of the two cervical images we collected in each case to produce the results presented in
this study. This undersampling of the cervix is a limitation of our approach given the natural
inhomogeneity of the cervix. This also may have increased the between-subject variability
because the same regions of the cervix were not compared in every case. In future studies,
our goal will be to develop methods to obtain attenuation estimates throughout the entire
cervix.
A further limitation of the study is that the attenuation estimation algorithm assumes that the
ROI is homogeneous (i.e. has the same attenuation and scattering properties). Therefore
inhomogeneities within the ROI could result in errors in the attenuation estimate. The best
way to reduce these errors is to increase the ROI size. Because the minimal ROI size needed
for accurate estimates is a function of wavelength, increasing the ultrasound frequency
(reducing the wavelength) is a relatively simple approach for reducing the sensitivity to
inhomogeneities. The smaller ROIs obtained at higher ultrasound frequencies could also
enhance our ability to obtain attenuation estimates at late gestational ages when the cervix
has a shorter length as a result of effacement42.
The small sample size of this study limits the generalizability of our findings. We are
encouraged by our preliminary findings that it may be possible to detect early cervical tissue
property changes in human pregnancy that lead to labor. In the future, we plan to conduct
studies with longitudinal repeated-measures designs to assess cervical attenuation
throughout pregnancy as a measure of the cervix preparing for labor.
Conclusions
It is clear that we still have much to learn about the mechanisms and processes of cervical
ripening1. New imaging technologies are necessary to fully understand and detect such
changes during pregnancy1. Significant technological advances in computing and
instrumentation have made it possible to improve the detection of tissue-property changes
associated with cervical ripening18,25,26,39,55–62. We postulate that it will be possible to
add attenuation assessment processing software to current clinical ultrasound systems with
RF data capabilities. Attenuation estimates have the potential to be an early and objective
non-invasive method of detecting changes in cervical tissue microstructure that are
consistent with cervical ripening.
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Figure 1.
Atomic force microscopy images of the cervix from (a) a non-pregnant rat, displaying
highly organized, pack bundles of collagen and (b) a cervix on day 21 of pregnancy,
displaying disorganized collagen with space between the fibrils. The bundles of collagen
that are displayed in these images are <0.1 µm. Rats typically deliver on day 21. (Image by
R. Bhargava, W. King, UIUC, and B. L. McFarlin, UIC).
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Figure 2.
Attenuation map for a B-mode image obtained from the tissue-mimicking phantom (the
phantom has a known attenuation coefficient of 0.64 dB/cm-MHz) using a 4–9-MHz
endovaginal transducer (z.one; Zonare Medical Systems, Inc.). Each pixel represents a mean
attenuation coefficient value for a region of interest. The mean (± SD) attenuation
coefficient measured for the phantom was 0.64 (± 0.13) dB/cm-MHz.
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Figure 3.
Scatterplots of ultrasonic attenuation coefficient estimates of the cervix in relation to
gestational age at the time of ultrasound examination (a), cervical length (b) and time
between ultrasound examination and delivery (c), showing linear regression lines and 95%
CIs. (a) A trend of decreasing attenuation as pregnancy approached full term (≥ 37 weeks
gestation) was observed (P = 0.15). Linear regression equation: y = −0.01 x+ 1.41; R2 =
0.055. (b) The relationship between cervical attenuation coefficient estimates and cervical
length was not significant (P = 0.65). Linear regression equation: y = 0.022 x + 1.10; R2 =
0.006. (c) Attenuation significantly predicted interval to delivery. Women with lower
cervical attenuation estimates delivered significantly earlier than women with higher
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cervical attenuation estimates (P = 0.011). Linear regression equation: y = 0.018 x + 0.932;
R2 = 0.100.
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Figure 4.
Ultrasound B-mode images (a,c) and B-mode images superimposed with maps of the mean
attenuation estimates (b,d) of two women in the study, one at 14 weeks of gestation, with
cervical length 31 mm (a,b) and the other at 38 weeks of gestation, with cervical length 35
mm (c,d). The colors of the regions of interest represent a mean attenuation (dB/cm-MHz)
consistent with the corresponding scale bar.
McFarlin et al. Page 15
Ultrasound Obstet Gynecol. Author manuscript; available in PMC 2011 August 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
McFarlin et al. Page 16
Table 1
Transducer performance characteristics as reported by Zonare Medical Systems, Inc
Transducer property Endovaginal 4–9 MHz
Number of elements 128
Center frequency (6 dB) 6.4 MHz (±0.2)
Bandwidth ≥ 65%
Focal length 33 mm (±10)
Pulse width (6 dB) ≤ 0.24 µs
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Table 2
Characteristics of the 40 study participants
Variable
All women
(n = 40)
Women delivering at
≥ 37 weeks
(n = 33)
Women delivering at
< 37 weeks
(n = 7)
Maternal age (years) 28 ± 6.7 (19–42) 28 ± 6.8 (19–42) 28 ± 8.4 (19–38)
Gravidity 2 (1–5) 2 (1–5) 2 (1–4)
History of PTL 7 1 6
History of PTD 7 1 6
GA at ultrasound (weeks) 22.5 ± 8.6 (10–40) 22.8 ± 8.9 (10–40) 23.4 ± 8.1 (12–35)
Attenuation (dB/cm-MHz) 1.19 ± 0.36 (0.31–1.9) 1.24 ± 0.31 (0.56–1.9) 1.06 ± 0.48 (0.31–1.62)
Interval from ultrasound to delivery (weeks) 14.6 ± 8.7 (0–29) 15.8 ± 8.2 (0–29) 9.4 ± 9.3 (1–24)
Cervical length (cm) 3.7 ± 1.32 (0.56–6.1) 3.8 ± 1.33 (0.56–6.1) 2.9 ± 1.53 (0.74–5.1)
GA at delivery (weeks) 37.6 ± 3.1 (27–41) 38.8 ± 1.1 (37–41) 32.5 ± 3.8 (27–36)
Birth weight (g) 2970 ± 7.95 (843–4223) 3224 ± 475 (2300–4223) 1891 ± 849 (843–3288)
Data are expressed as n, mean ± SD (range) or median (range). GA, gestational age; PTD, preterm delivery (< 37 weeks); PTL, preterm labor (< 37
weeks).
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